Vendor, Princeton, NJ
Rizlab Health Inc.
UEI H75CJVCZZNP3, CAGE 87FJ6
1 award and $0 obligated between June 26, 2024 and February 9, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50123C00028Definitive Contract, June 26, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Research and Development- Aoi #16+ Seeking to Manufacture and Obtain Regulatory Approval for the Cytotracker Bv, a Point-Of-Care Instant WhiNAICS 541714, PSC AN13 | $0 |
- Places of performance
- New Jersey
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 2 across 1 awards